Dean Slagel, Director at Cara Therapeutics, Inc. (CARA), sold 75,224 shares at $17.00 ($1.3M) on 2015-12-31, disclosed to the SEC on 2016-01-12.
Open-market sale of $1.3M CARA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 12,776 | $217K | 17.0% |
| 2 | $17.01 | 31,224 | $531K | 41.5% |
| 3 | $17.01 | 31,224 | $531K | 41.5% |
| Total | $17.01 avg | 75,224 | $1.3M | 100% |
| Filing → |